Literature DB >> 9855016

Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis.

Q S Wang1, A Papanikolaou, C L Sabourin, D W Rosenberg.   

Abstract

Alterations in the expression of the cell cycle regulators, cyclin D1 and cyclin-dependent kinase 4 (Cdk4), have been implicated in malignancies of both humans and experimental animal models. We hypothesize that altered expression of cyclin D1 and Cdk4 may also be involved in mouse colon tumorigenesis induced by the chemical carcinogen, azoxymethane (AOM). In the present study, SWR/J mice were given AOM by i.p. injection at a dose of 10 mg/kg once a week for 8 weeks, and colonic tissue and tumors were isolated 18 weeks later. The expression and localization of cyclin D1 and Cdk4 were examined by reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemical analyses. Cyclin D1 and Cdk4 mRNA levels in tumor samples were increased 1.3-fold (P < 0.01) and 1.2-fold (P < 0.01), respectively, when compared with control mouse colon tissue. Control colon epithelium was uniformly negative for cyclin D1 immunoreactivity, whereas minimal Cdk4 nuclear staining was confined to the lower portion of the crypts within the control tissue. Both cyclin D1 and Cdk4 immunoreactive cells were markedly increased in preneoplastic lesions and in adenomas isolated from AOM-treated mice. Furthermore, some morphologically normal colon crypts from AOM-treated mice showed positive cyclin D1 immunoreactivity. These findings suggest that overexpression of cyclin D1 and Cdk4 occurs early in the AOM-induced mouse colon tumorigenesis and may contribute to tumor progression in this model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855016     DOI: 10.1093/carcin/19.11.2001

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  Over-expression of cyclin D1 regulates Cdk4 protein synthesis.

Authors:  M A Parker; N G Deane; E A Thompson; R H Whitehead; S K Mithani; M K Washington; P K Datta; D A Dixon; R D Beauchamp
Journal:  Cell Prolif       Date:  2003-12       Impact factor: 6.831

2.  Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.

Authors:  Nanjoo Suh; Bandaru S Reddy; Andrew DeCastro; Shiby Paul; Hong Jin Lee; Amanda K Smolarek; Jae Young So; Barbara Simi; Chung Xiou Wang; Naveena B Janakiram; Vernon Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-15

3.  NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.

Authors:  Rajendra Karki; R K Subbarao Malireddi; Qifan Zhu; Thirumala-Devi Kanneganti
Journal:  Cell Cycle       Date:  2017-06-09       Impact factor: 4.534

4.  Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.

Authors:  Alessandro Fichera; Nathaniel Little; Sujatha Jagadeeswaran; Urszula Dougherty; Amikar Sehdev; Reba Mustafi; Sonia Cerda; Weihua Yuan; Sharad Khare; Maria Tretiakova; Can Gong; Michael Tallerico; Greg Cohen; Loren Joseph; John Hart; Jerrold R Turner; Marc Bissonnette
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

5.  Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway.

Authors:  Pandurangan Ashokkumar; Ganapasam Sudhandiran
Journal:  Invest New Drugs       Date:  2009-12-15       Impact factor: 3.850

Review 6.  Murine models of colorectal cancer.

Authors:  Joshua M Uronis; David W Threadgill
Journal:  Mamm Genome       Date:  2009-05-15       Impact factor: 2.957

7.  Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats.

Authors:  Shiby Paul; Andrew J DeCastro; Hong Jin Lee; Amanda K Smolarek; Jae Young So; Barbara Simi; Chung Xiou Wang; Renping Zhou; Agnes M Rimando; Nanjoo Suh
Journal:  Carcinogenesis       Date:  2010-01-08       Impact factor: 4.944

8.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

Authors:  Mariangela De Robertis; Emanuela Massi; Maria Luana Poeta; Simone Carotti; Sergio Morini; Loredana Cecchetelli; Emanuela Signori; Vito Michele Fazio
Journal:  J Carcinog       Date:  2011-03-24

9.  Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.

Authors:  Feng Tian; Ding Ding; Dandan Li
Journal:  Int J Oncol       Date:  2015-04-09       Impact factor: 5.650

10.  Joint network and node selection for pathway-based genomic data analysis.

Authors:  Shandian Zhe; Syed A Z Naqvi; Yifan Yang; Yuan Qi
Journal:  Bioinformatics       Date:  2013-06-08       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.